Assessment of the appropriateness of STOPP/START criteria in primary health care in Spain by the RAND method;Valoración de la idoneidad de los criterios STOPP/START en el ámbito de atención primaria en España por el método RAND

Semergen

Volumn 39, Issue 8, 2013, Pages 413-420

  Castillo Paramo A ^a   Pardo Lopo, R ^b   Gomez Serranillos I R ^a   Verdejo, A ^c   Figueiras, A ^d   Claveria A ^a  

^a Gerencia de Atención Primaria de Vigo ^*  (Spain)

^b Farmacia Carballal Estévez   (Spain)

^c Gerencia de Atención Primaria de Vigo   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Elderly; Inappropriate prescribing; Polypharmacy; Primary health care; STOPP START

Indexed keywords

CROSS-SECTIONAL STUDY; EVALUATION STUDY; HUMAN; INAPPROPRIATE PRESCRIBING; PRESCRIPTION; PREVENTION AND CONTROL; PRIMARY HEALTH CARE; SPAIN; STANDARDS;

CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; PRIMARY HEALTH CARE; SPAIN;

EID: 84889654507     PISSN: 11383593     EISSN: 15788865     Source Type: Journal    
DOI: 10.1016/j.semerg.2013.01.017     Document Type: Article

References (30)

1. O'Mahony D., Gallagher P.F. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008, 37:138-141.
2. Hakkarainen KM, Hedna K, Petzold M, Hägg S. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions -a meta-analysis. PLoS ONE. 2012;7, e33236. doi:10.1371/journal.pone.0033236.
3. Patterson S.M., Hughes C., Kerse N., Cardwell C.R., Bradley M.C. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012, CD008165. 10.1002/14651858.CD008165.pub2.
4. Matanovic S.M., Vlahovic-Palcevski V. Potentially inappropriate medications in the elderly: a comprehensive protocol. Eur J Clin Pharmacol 2012, 68:1123-1138.
5. Delgado Silveira E., Muñoz García M., Montero Errasquin B., Sánchez Castellano C., Gallagher P.F., Cruz-Jentoft A.J. Inappropriate prescription in older patients: the STOPP/START criteria. Rev Esp Geriatr Gerontol 2009, 44:273-279.
6. Gallagher P., Ryan C., Byrne S., Kennedy J., O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008, 46:72-83.
7. Ryan C., O'Mahony D., Kennedy J., Weedle P., Byrne S. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol 2009, 68:936-947.
8. Fitch K, Bernstein SJ, Aguilar MS, Burnand B, La Calle JR, Lázaro P, et al. The RAND/UCLA appropriateness method user's manual Internet. RAND Health Santa Mónica; 2001 [consultado 12 Nov 2011]. Disponible en: http://www.rand.org/pubs/monograph_reports/MR1269.html.
9. Quintana J.M., Cabriada J., de Tejada I.L., Varona M., Oribe V., Barrios B., et al. Development of explicit criteria for cholecystectomy. Qual Saf Health Care 2002, 11:320-326.
10. Holt S., Schmiedl S., Thürmann P.A. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010, 107:543-551.
11. Rognstad S., Brekke M., Fetveit A., Spigset O., Wyller T.B., Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 2009, 27:153-159.
12. Shekelle P.G., MacLean C.H., Morton S.C., Wenger N.S. Acove quality indicators. Ann Intern Med 2001, 135(8 Pt 2):653-667.
13. Gallagher P.F., O'Connor M.N., O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011, 89:845-854.
14. Shane E., Burr D., Ebeling P.R., Abrahamsen B., Adler R.A., Brown T.D., et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the american society for bone and mineral research. J Bone Miner Res 2010, 25:2267-2294.
15. de Berardis G., Sacco M., Strippoli G.F.M., Pellegrini F., Graziano G., Tognoni G., et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 2009, 339:4531.
16. de Burgos Lunar C., Novo del Castillo S., Llorente Díaz E., Salinero Fort M.A. Estudio de prescripción-indicación de inhibidores de la bomba de protones. Rev Clin Esp 2006, 206:266-270.
17. Agencia Española de Medicamentos y Productos Sanitarios Internet. Nota informativa de la Agencia Española de Medicamentos y Productos Sanitarios sobre Interacción de Clopidogrel con los Inhibidores de la Bomba de Protones: actualización de la información y recomendaciones de uso; 26 de Abr de 2011 [consultado 20 Nov 2011]. Disponible en: http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2010/NI_2010-04_clopidogrel.htm.
18. Reimer C., Sondergaard B., Hilsted L., Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009, 137:80-87.
19. King R.N., Lager S.L. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy. Pharmacotherapy 2011, 31:642-648.
20. Topliss D, Gold M, Kotsirilos V, Lander C, McNeil J, Pillans P, et al. Proton pump inhibitors and possible fracture risk. Aust Adv Drug Reactions Bull. 2009;28:1.
21. Agencia Española de Medicamentos y Productos Sanitarios Internet. Notas informativas de la Agencia Española de Medicamentos y Productos Sanitarios sobre Riesgo de hipomagnesemia asociado a los medicamentos inhibidores de la bomba de protones (IBP), 23 de diciembre de 2011 [consultado 2 Ene 12]. Disponible en: http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2011/NI-MUH_27-2011.htm.
22. Lang P.O., Hasoo Y., Belmin J., Payot I., Baeyens J.P., Vogt-Ferrier N., et al. STOPP-START: Adaptation en langue francaise d'un outil de detection de la prescription médicamente use inappropriée chez la personne âgée. Rev Can Santé Publique 2009, 100:426-431.
23. Lertxundi U., Peral J., Hernández R. Comentarios a la versión en español de los criterios STOPP/START carta al editor. Rev Esp Geriatr Gerontol 2011, 46:170-171.
24. Gallagher P., Baeyens J.P., Topinkova E., Madlova P., Cherubini A., Gasperini B., et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009, 38:603-606.
25. Montero-Errasquin B., Sanchez-Cuervo M., Sanchez-Castellano C., Delgado-Silveira E., Bermejo-Vicedo T., Cruz-Jentoft A. Inappropriate prescription in geriatric outpatients: A comparison of two instruments. J Nutr Health Aging 2008, 12:585.
26. Gallagher P., O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37:673-679.
27. Herreros Herreros Y., López-Torres Hidalgo J.D., de-Hoyos Alonso M.C., Baena Díez J.M., Gorroñogoitia Iturbe A., Martín Lesende I. Grupo de expertos del PAPPS. Actividades preventivas en los mayores. Aten Primaria 2012, 44(Supl 1):S57-S64.
28. Alfaro Lara ER, Maria Dolores Vega Coca MD, Galván Banqueri M, Marín Gil R, Nieto Martín MD, Pérez Guerrero C, et al. Selection of tools for reconciliation compliance and appropriateness of treatment in patients with multiple chronic conditions. Eur J Intern Med. 2012; 23:506-12.
29. Ryan C., O'Mahony D., Byrne S. Application of STOPP and START Criteria: Interrater reliability among pharmacists. Ann Pharmacother 2009, 43:1239-1244.
30. Ivers N., Jamtvedt G., Flottorp S., Young J.M., Odgaard-Jensen J., French S.D. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database of Systematic Reviews 2012, CD000259. 10.1002/14651858.CD000259.pub3.